Coronavirus Update: Novartis Joins Vaccine Efforts With Gene Therapy Approach

Plus: Oxford BioMedica, And Rehab Needs Of COVID-19 Survivors

Having kept out of the race to develop a vaccine until now, Novartis has joined efforts with a collaboration using the AAV gene therapy vector.

Floor_Sign_2m
Easing lockdown: The UK is cautiously lifting lockdown restrictions, but fears of a second wave remain high as the daily death toll remains above 300.

More from Business

More from Scrip